Tyrvaya is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Oyster Point Pharma. The primary component is Varenicline.
Product ID | 73521-030_1b36343e-1b34-4a54-a43f-4b53ad3edc80 |
NDC | 73521-030 |
Product Type | Human Prescription Drug |
Proprietary Name | Tyrvaya |
Generic Name | Varenicline |
Dosage Form | Spray |
Route of Administration | NASAL |
Marketing Start Date | 2021-10-20 |
Marketing Category | NDA / |
Application Number | NDA213978 |
Labeler Name | Oyster Point Pharma |
Substance Name | VARENICLINE |
Active Ingredient Strength | 0 mg/.05mL |
Pharm Classes | Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-10-20 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
73521-030 | Tyrvaya | varenicline |
60505-4765 | APO-VARENICLINE | VARENICLINE |
60505-4766 | APO-VARENICLINE | VARENICLINE |
60505-4767 | APO-VARENICLINE | VARENICLINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TYRVAYA 88873736 not registered Live/Pending |
Oyster Point Pharma, Inc. 2020-04-15 |
TYRVAYA 88791700 not registered Live/Pending |
Oyster Point Pharma, Inc. 2020-02-10 |